A. Yap

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.

D. Fabbro, Dylan T. Jones, K. Ganeshaguru, 2002, The hematology journal : the official journal of the European Haematology Association.

Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapy.

K. James, R. Fish, A. Yap, 1982, Clinical biochemistry.

Combination of cisplatin and interferon-alpha 2a (Roferon-A) in patients with non-small cell lung cancer (NSCLC). An open phase II multicentre study.

V. Kataja, A. Yap, 1995, European journal of cancer.

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study

D. Bowtell, J. Zalcberg, M. Millward, 2006, British Journal of Cancer.

A phase I/II trial of the oral mTOR-inhibitor everolimus (E) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM: Study update

J. Blay, J. Fletcher, G. Demetri, 2005 .

Rapid and inexpensive enzyme inhibition assay of methotrexate.

D. Luscombe, A. Yap, 1986, Journal of pharmacological methods.

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

M Buyse, M. Buyse, R. Schilsky, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.

Jennifer Hayes Clark, E. Estey, D. Neuberg, 2004, Annals of hematology.

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.

G. Batist, T. Shore, F. Porzsolt, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.

Jennifer Hayes Clark, E. Estey, D. Neuberg, 2004, Annals of hematology.

Acute phase glycoproteins in sera of patients with sarcomas receiving methotrexate infusion therapy.

R. Fish, C. Keen, A. Yap, 1985, Clinical biochemistry.